STACIE MCHAN JONES, MD
Medical Practice in Little Rock, AR
License number
Arkansas C-7726
Category
Medical Practice
Type
Pediatric Allergy/Immunology
Address
Address
1 CHILDREN'S Way #653, Little Rock, AR 72202
Phone
(501) 364-1100
Personal information
See more information about STACIE MCHAN JONES at radaris.comName
Address
Phone
64 Point West Cir, Little Rock, AR 72211
Professional information
Dr. Stacie M Jones, Little Rock AR - MD (Doctor of Medicine)
Specialties:
Pediatrics, Allergy & Immunology
Address:
UNIVERSITY OF ARKANSAS CHILDRENS HOSPITAL
1 Childrens Way SUITE 653, Little Rock 72202
(501) 364-4000 (Phone)
Childrens Hospital Pediatric
1 Childrens Way SUITE 2, Little Rock 72202
(501) 364-1060 (Phone)
1 Childrens Way SUITE 653, Little Rock 72202
(501) 364-4000 (Phone)
Childrens Hospital Pediatric
1 Childrens Way SUITE 2, Little Rock 72202
(501) 364-1060 (Phone)
Certifications:
Allergy & Immunology, 1995, Pediatrics, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Arkansas For Medical Sciences
Graduated: 1989
University Ar Med Scis/Ark Chldns Hospital
University Ar Med Scis/Ar Chldns Hospital
Johns Hopkins University Med Center
University of Arkansas For Medical Sciences
Graduated: 1989
University Ar Med Scis/Ark Chldns Hospital
University Ar Med Scis/Ar Chldns Hospital
Johns Hopkins University Med Center
Stacie McHan Jones, Little Rock AR
Specialties:
Allergy & Immunology, Pediatrics, Pediatric Allergy & Immunology
Work:
Arkansas Children's Hospital
1 Childrens Way, Little Rock, AR 72202 University of Arkansas
4301 W Markham St, Little Rock, AR 72205
1 Childrens Way, Little Rock, AR 72202 University of Arkansas
4301 W Markham St, Little Rock, AR 72205
Education:
University of Arkansas(1989)
Recombinant Beta2-Adrenergic Receptor Delivery And Use In Treating Airway And Vascular Diseases
US Patent:
2002002, Mar 7, 2002
Filed:
Feb 15, 2001
Appl. No.:
09/783580
Inventors:
Lawrence Cornett - Little Rock AR, US
F. Hiller - Little Rock AR, US
Stacie Jones - Little Rock AR, US
F. Hiller - Little Rock AR, US
Stacie Jones - Little Rock AR, US
International Classification:
A61K048/00
US Classification:
424/093210, 514/044000, 435/320100
Abstract:
A method of treating a human subject having airway or vascular disease is disclosed that comprises administering to at least one cell type selected from the group consisting of airway epithelial cells, airway smooth muscle cells, blood vessel endothelial cells, and blood vessel smooth muscle cells, a first composition comprising a vector comprising a DNA sequence encoding a AR (p-adrenergic receptor) or a mutant thereof, operably linked to a promoter that is functional in at least one of said cells said subject, under conditions whereby the DNA sequence encoding the AR is expressed in at least one of the cells; and optionally administering a second composition comprising at least one -adrenergic agonist into the cells of said subject. A further pharmaceutical composition may be administered comprising a hormone or pharmacological agent that induces the promoter to express the AR in at least one of the target cells. Pharmaceutical compositions comprising the vector comprising a DNA sequence encoding a AR or a mutant thereof, operably linked to a promoter that is functional in at least one of the cells of the subject and kits containing these compositions are also disclosed. An in vitro method of expressing the AR gene in mammalian cells and a method of evaluating the effect of pharmacological compounds on the expression of the AR gene is disclosed.